Developing new economic models to incentivise antibiotic discovery and development activities while safeguarding the efficacy of antibiotics by researching and advocating their appropriate use.
DRIVE-AB final conference_Overview and materials
The final DRIVE-AB conference, “Revitalizing the antibiotic pipeline: Stimulating innovation while driving sustainable use and global access”, was...
Revitalizing the Antibiotic Pipeline: DRIVE-AB Conference Speakers Announced
Economic Incentives for Antimicrobial Drugs Proposed by Duke-Margolis Centre
The Duke-Margolis Centre for Health Policy in the United States has released a paper describing U.S. policy approaches that...
DRIVE-AB Steering Committee Publishes Advice to G20 Leaders in The Lancet Infectious Diseases
In anticipation of the 2017 G20 Summit in Hamburg, Germany, on 7-8 July, the...